Evolent Health (EVH)
(Delayed Data from NYSE)
$31.04 USD
+0.23 (0.75%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $31.10 +0.06 (0.19%) 7:58 PM ET
3-Hold of 5 3
C Value A Growth F Momentum B VGM
Evolent Health (EVH) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$41.86 | $63.00 | $31.00 | 35.86% |
Price Target
Based on short-term price targets offered by 14 analysts, the average price target for Evolent Health comes to $41.86. The forecasts range from a low of $31.00 to a high of $63.00. The average price target represents an increase of 35.86% from the last closing price of $30.81.
Analyst Price Targets (14)
Broker Rating
Evolent Health currently has an average brokerage recommendation (ABR) of 1.07 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 15 brokerage firms. The current ABR compares to an ABR of 1.07 a month ago based on 15 recommendations.
Of the 15 recommendations deriving the current ABR, 14 are Strong Buy and one is Buy. Strong Buy and Buy respectively account for 93.33% and 6.67% of all recommendations. A month ago, Strong Buy made up 93.33%, while Buy represented 6.67%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 14 | 14 | 14 | 13 | 13 |
Buy | 1 | 1 | 1 | 1 | 1 |
Hold | 0 | 0 | 0 | 1 | 1 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.07 | 1.07 | 1.07 | 1.20 | 1.20 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
8/9/2024 | Truist Securities | Jailendra Singh | Hold | Strong Buy |
8/9/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
8/9/2024 | JMP Securities | Constantine Kyriakos Davides | Strong Buy | Strong Buy |
8/9/2024 | Not Identified | Not Identified | Moderate Buy | Moderate Buy |
8/9/2024 | Piper Sandler | Jessica E Tassan | Strong Buy | Strong Buy |
8/9/2024 | Cowen & Co. | Charles Rhyee | Strong Buy | Strong Buy |
8/8/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
8/8/2024 | William Blair | Ryan S Daniels | Strong Buy | Strong Buy |
8/1/2024 | UBS | Kevin Caliendo | Strong Buy | Strong Buy |
7/30/2024 | Stephens | Jeffrey Garro | Strong Buy | Strong Buy |
5/30/2024 | Guggenheim Securities | Jack D Wallace | Strong Buy | Strong Buy |
4/22/2024 | Not Identified | Not Identified | Not Available | Strong Buy |
3/28/2024 | Canaccord Genuity | Richard Close | Strong Buy | Strong Buy |
1/7/2024 | BTIG | David M Larsen | Strong Buy | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.07 |
ABR (Last week) | 1.07 |
# of Recs in ABR | 15 |
Average Target Price | $41.86 |
LT Growth Rate | NA |
Industry | Internet - Software |
Industry Rank by ABR | 75 of 253 |
Current Quarter EPS Est: | 0.29 |
EVH FAQs
Evolent Health, Inc (EVH) currently has an average brokerage recommendation (ABR) of 1.07 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 15 brokerage firms.
The average price target for Evolent Health, Inc (EVH) is $41.86. The current on short-term price targets is based on 4 reports.
The forecasts for Evolent Health, Inc (EVH) range from a low of $31 to a high of $63. The average price target represents a increase of $34.86 from the last closing price of $31.04.
The current UPSIDE for Evolent Health, Inc (EVH) is 34.86%
Based on short-term price targets offered by 14 analysts, the average price target for Evolent Health comes to $41.86. The forecasts range from a low of $31.00 to a high of $63.00. The average price target represents an increase of 35.86% from the last closing price of $30.81.